Dr. Jay C Andersen, MD
Claim this profileNorthwest Cancer Specialists, P.C.
Studies Breast Cancer
8 reported clinical trials
16 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Jay C Andersen, MD is currently running
ARX788
for HER2-Positive Breast Cancer
This trial tests ARX788, a new IV medicine, for patients with HER2-positive metastatic breast cancer who did not respond well to T-DXd. The medicine targets a specific protein on cancer cells to help stop their growth.
Recruiting1 award Phase 28 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
More about Jay C Andersen, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jay C Andersen, MD has experience with
- Tucatinib
- Placebo
- Trilaciclib
- T-DM1
- Trastuzumab Deruxtecan
- Abemaciclib
Breakdown of trials Jay C Andersen, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jay C Andersen, MD specialize in?
Jay C Andersen, MD focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jay C Andersen, MD currently recruiting for clinical trials?
Yes, Jay C Andersen, MD is currently recruiting for 2 clinical trials in Tigard Oregon. If you're interested in participating, you should apply.
Are there any treatments that Jay C Andersen, MD has studied deeply?
Yes, Jay C Andersen, MD has studied treatments such as Tucatinib, Placebo, Trilaciclib.
What is the best way to schedule an appointment with Jay C Andersen, MD?
Apply for one of the trials that Jay C Andersen, MD is conducting.
What is the office address of Jay C Andersen, MD?
The office of Jay C Andersen, MD is located at: Northwest Cancer Specialists, P.C., Tigard, Oregon 97223 United States. This is the address for their practice at the Northwest Cancer Specialists, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.